Peter Anderson, DC
Medical · McMinnville, ORNPI 1144337916
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 210 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,869, more than ten times the $91 reported in 2021. Among medical clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 210 payments — averaging $19.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$660
- Viiv Healthcare Company$463
- Amgen$383
- Gilead$335
- Insmed, Inc.$301
- Melinta Therapeutics, LLC$298
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,03898%
- Education$1012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $660 |
| Viiv Healthcare Company | 28 | $463 |
| Amgen | 18 | $383 |
| Gilead | 19 | $335 |
| Insmed, Inc. | 18 | $301 |
| Melinta Therapeutics, LLC | 24 | $298 |
| Aimmune Therapeutics, Inc. | 9 | $284 |
| Daiichi Sankyo Inc. | 8 | $173 |
| Astellas Pharma US Inc | 5 | $136 |
| Johnson & Johnson | 5 | $130 |
| Tersera Therapeutics LLC | 5 | $130 |
| Nestle Healthcare Nutrition Inc. | 5 | $95 |
| UCB, Inc. | 5 | $83 |
| Novartis | 3 | $76 |
| Merck | 4 | $76 |
| Organon | 2 | $52 |
| GSK | 2 | $50 |
| Pfizer | 3 | $50 |
| Smith+Nephew | 1 | $41 |
| Shionogi Inc | 2 | $41 |
| Kyowa Kirin, Inc. | 2 | $38 |
| Ferring Pharmaceuticals Inc. | 2 | $36 |
| AstraZeneca | 1 | $31 |
| Theratechnologies Inc. | 2 | $28 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Octapharma USA, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Urgo Medical North America, LLC | 1 | $17 |
| Pharming Healthcare, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZENPEP$125
How this compares
$4,139 in reported general payments places this provider in the 95th percentile of 364 medical providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Vancomycin Hcl | 50 | $4,996 |
| Cephalexin | 122 | $4,727 |
| Cefpodoxime Proxetil | 11 | $3,353 |
| Doxycycline Hyclate | 81 | $2,413 |
| Daptomycin | 14 | $2,345 |
| Fosfomycin Tromethamine | 16 | $2,325 |
| Fluconazole | 28 | $1,659 |
| Vancomycin HclVancomycin/Water For Inj (Peg) | 11 | $1,553 |
| Ciprofloxacin Hcl | 41 | $1,084 |
| Amoxicillin | 56 | $686 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 23 | $542 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 28 | $476 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $467 |
| Penicillin V Potassium | 14 | $410 |
| Ondansetron Hcl | 23 | $209 |
Paid to pharmacies, not to this prescriber.
Other medical in McMinnville
- Mark DavisLake Oswego$12K
- Britt BennPortland$11K
- Benjamin WillettSalem$11K
- Jeffrey RennaSalem$9K
- Christy SnoSpringfield$8K
- Erica BallardPortland$8K
- Nicole WydraCorvallis$8K
- Caitlyn EricksonHillsboro$6K
- Brolin JohnsonSalem$6K
- Maci PfaffenbergerGresham$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.